Inventor
RAU HARALD
DE70 patents
⚠️ This page may combine multiple inventors who share the name “RAU HARALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASCENDIS PHARMA GROWTH DISORDERS AS
11 patentsUS10835578B2Nov 17, 2020
CNP prodrugs with large carrier moieties
ASCENDIS PHARMA GROWTH DISORDERS AS21 citations93
US11389511B2Jul 19, 2022
Controlled-release CNP agonists with reduced side-effects
ASCENDIS PHARMA GROWTH DISORDERS AS7 citations85
US11413351B2Aug 16, 2022
CNP prodrugs with carrier attachment at the ring moiety
ASCENDIS PHARMA GROWTH DISORDERS AS7 citations84
US11154593B2Oct 26, 2021
CNP prodrugs with large carrier moieties
ASCENDIS PHARMA GROWTH DISORDERS AS13 citations84
US11389510B2Jul 19, 2022
Controlled-release CNP agonists with low initial NPR-B activity
ASCENDIS PHARMA GROWTH DISORDERS AS5 citations83
US11224661B2Jan 18, 2022
Controlled-release CNP agonists with increased NEP stability
ASCENDIS PHARMA GROWTH DISORDERS AS7 citations80
US12083182B2Sep 10, 2024
Controlled-release CNP agonists with increased NEP stability
ASCENDIS PHARMA GROWTH DISORDERS AS3 citations74
US12156917B2Dec 3, 2024
CNP prodrugs with carrier attachment at the ring moiety
ASCENDIS PHARMA GROWTH DISORDERS AS2 citations73
US11311604B2Apr 26, 2022
Controlled-release CNP agonists with low NPR-C binding
ASCENDIS PHARMA GROWTH DISORDERS AS6 citations72
US12239689B2Mar 4, 2025
Controlled-release CNP agonists with low initial NPR-B activity
ASCENDIS PHARMA GROWTH DISORDERS AS1 citations64
US12544428B2Feb 10, 2026
Controlled-release CNP agonists with reduced side-effects
ASCENDIS PHARMA GROWTH DISORDERS AS0 citations62
GOLDSCHMIDT AG TH
7 patentsUS5910564AJun 8, 1999
Polyamino acid ester copolymers
GOLDSCHMIDT AG TH157 citations98
US4452961AJun 5, 1984
Process for the synthesis of heat-curable silicone resins
GOLDSCHMIDT AG TH20 citations81
US4609752ASep 2, 1986
Process and apparatus for continuously synthesizing alkoxypolysiloxanes
GOLDSCHMIDT AG TH25 citations78
US4898772AFeb 6, 1990
Abhesive coating preparation and method of abhesively coating utensils
GOLDSCHMIDT AG TH8 citations73
US4487809ADec 11, 1984
Process for the synthesis of a water-dilutable, heat-curable organopolysiloxane, modified with organic polyols
GOLDSCHMIDT AG TH9 citations73
US4408031AOct 4, 1983
Process for the preparation of heat-curable silicone resins usable especially as electrical insulating resins
GOLDSCHMIDT AG TH13 citations73
US4281147AJul 28, 1981
Process for the production of aqueous solutions of alkali organosiliconates
GOLDSCHMIDT AG TH12 citations73
ASCENDIS PHARMA AS
6 patentsUS7968085B2Jun 28, 2011
Hydrogel formulations
ASCENDIS PHARMA AS37 citations96
US7879588B2Feb 1, 2011
Protein-proteophore complexes
ASCENDIS PHARMA AS19 citations92
US10980860B2Apr 20, 2021
Diagnosis, prevention and treatment of diseases of the joint
ASCENDIS PHARMA AS11 citations83
US9278139B2Mar 8, 2016
Sterilization of biodegradable hydrogels
ASCENDIS PHARMA AS7 citations83
US10029015B2Jul 24, 2018
Hydrogel formulations
ASCENDIS PHARMA AS2 citations73
US9913912B2Mar 13, 2018
Carrier-linked prostanoid prodrugs
ASCENDIS PHARMA AS2 citations72
RAU HARALD
5 patentsUS9173953B2Nov 3, 2015
Prodrugs containing an aromatic amine connected by an amido bond to a linker
RAU HARALD22 citations89
US9272048B2Mar 1, 2016
PEGylated recombinant human growth hormone compounds
RAU HARALD15 citations87
US9062094B2Jun 23, 2015
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
RAU HARALD15 citations83
US8986609B2Mar 24, 2015
Sterilization of biodegradable hydrogels
RAU HARALD6 citations82
US9561285B2Feb 7, 2017
Carrier-linked carbamate prodrug linkers
RAU HARALD4 citations72
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S
5 patentsUS10960053B2Mar 30, 2021
PEGylated recombinant human growth hormone compounds
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S5 citations82
US9919033B2Mar 20, 2018
Dry growth hormone composition transiently linked to a polymer carrier
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S10 citations82
US10799563B2Oct 13, 2020
Polymeric hGH prodrugs
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S10 citations79
US12133883B2Nov 5, 2024
Polymeric hGH prodrugs
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S2 citations68
US12274737B2Apr 15, 2025
PEGylated recombinant human growth hormone compounds
ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S0 citations60
UNIV NEW YORK STATE RES FOUND
3 patentsUS5828991AOct 27, 1998
Sentence reconstruction using word ambiguity resolution
UNIV NEW YORK STATE RES FOUND254 citations97
US5960385ASep 28, 1999
Sentence reconstruction using word ambiguity resolution
UNIV NEW YORK STATE RES FOUND100 citations96
US7440889B1Oct 21, 2008
Sentence reconstruction using word ambiguity resolution
UNIV NEW YORK STATE RES FOUND19 citations91
HERSEL ULRICH
2 patentsCLEEMANN FELIX
2 patentsCOMPLEX BIOSYSTEMS GMBH
1 patentRASMUSSEN GRETHE NØRSKOV
1 patentSANOFI AVENTIS DEUTSCHLAND
1 patentASCENDIS PHARMA ENDOCRINOLOGY DIV
1 patentASCENDIS PHARMA GROWTH DISORDERS DIV A/S
1 patentSPROGOE KENNETT
1 patentSPROGØE KENNETT
1 patentASCENDIS PHARMA OPHTHALMOLOGY DIV A/S
1 patentKRAUSS JOACHIM
1 patentShowing the top 50 of 70 patents by PatentIndex Score.